Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Christian Confavreux, Paul O'Connor, Giancarlo Comi, Mark Freedman, Aaron Miller, Tomas Olsson, Jerry Wolinsky, Teresa Bagulho, Jean-Luc Delhay, Deborah Dukovic, Philippe Truffinet, Ludwig Kappos, TOWER TRIAL GROUP TOWER TRIAL GROUP, Mark Slee

    Research output: Contribution to journalArticlepeer-review

    302 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences